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receiving haemodialysis, and their
caregivers: a mixed methods study protocol
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Abstract
Background: Globally 10% of the population worldwide are affected by chronic kidney disease (CKD), making it
one of the most prevalent chronic diseases. Several studies have highlighted that the symptoms of CKD have a
significant impact on patients. A number of symptoms, including fatigue and depression, are associated with poor
patient health, increased risk of hospitalisation and mortality. Physical and emotional symptoms often remain
under-recognised and largely untreated; however, patients often create a variety of self-management strategies to
meet the challenges of these symptoms. There is a lack of knowledge regarding symptom burden and the
experiences of patients receiving haemodialysis (HD) and their caregivers, particularly in Saudi Arabia, therefore, this
study aims to explore symptom burden and its management amongst patients receiving HD in addition to
caregiver burden.
Method: A mixed methods, sequential, explanatory design consisting of two phases: phase 1 involves a cross-
sectional study design with a planned convenience sample size of 141 patients who will be recruited from King
Khaled hospital, Saudi Arabia. Thirty-two physical and psychological symptoms will be measured using the Chronic
Kidney Disease-Symptom Burden Index (CKD-SBI). Additionally, 130 caregivers will complete the Arabic version of
the Zarit Burden Interview (ZBI-22) to identify the level of burden in the caregivers of patients on maintenance HD.
Phase 2 of the study is a qualitative descriptive design involving semi-structural interviews with 15 eligible patients
currently receiving HD. The selection of participants for interviews will be based on the patients’ total CKD-SBI
scores with five individuals recruited from the lowest, median and highest percentiles. Additionally, 15 caregivers of
the patients to be interviewed, will also be recruited and interviewed.
Discussion: This study focuses on a wide number of physical and psychological symptoms experienced by patients
receiving HD. It will also focus on the effective management strategies patients employ to help reduce their
perceived symptoms. Burden in caregivers of patients receiving HD will also be explored. Furthermore, the
association between symptom burden and caregiver burden will be investigated. Findings from this study will
provide evidence to help health care providers to develop effective interventions to assess and manage symptoms
in patients receiving HD.
Keywords: Symptom burden, Symptoms, Management, Haemodialysis, Dialysis, End-stage kidney disease, Chronic
kidney disease, Caregiver, Burden, Saudi Arabia, Mixed methods research
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Background
Chronic kidney disease (CKD) is an escalating global
health problem. It is characterized by a gradual decrease
in the ability of the kidneys to function effectively over
time [1]. According to the National Kidney Foundation
[1], 10% of the population worldwide are impacted by
CKD, making it one of the most prevalent chronic
diseases. Currently, Saudi Arabia and Belgium have the
highest estimated CKD prevalence (24%), followed by
UK and Singapore (16%). Norway and the Netherlands
have the lowest estimates at 5% [2]. The treatment that
is most preferred in end-stage renal disease (ESRD) is
renal transplantation [3]. However, this treatment is not
always possible due to a shortage of donors and appro-
priate medical facilities [4–6] or the ineligibility of recip-
ients for kidney transplantation due to their health
condition [6, 7]. Hence most patients rely on dialysis
treatment. Approximately 90% of all patients receiving
dialysis are undergoing HD [6]. Although dialysis is life-
saving, patients on maintenance HD experience multiple
physical and emotional symptoms that impact on their
well-being [8]. HD is exhausting for patients who com-
monly experience a range of symptoms such as fatigue,
depression, anxiety, itching, vomiting and nausea [9–11].
Controlling symptoms in patients receiving HD is
essential and requires comprehensive prior assessment.
However, studies claim that healthcare providers fail to
commonly recognise and treat the physical and emo-
tional symptoms experienced by patients receiving HD
[12]. In a recent study, the main barriers to symptom
management is that health care providers are unaware of
patient symptoms [13]. According to Solano [14], pa-
tients with ESRD experience a similar degree of symp-
tom distress to cancer patients. Several studies suggest
that patients with symptom burden create a self-
management strategy to help reduce or, relieve and cope
with their chronic disease symptoms [15–17]. The devel-
opment and use of these self-management strategies
requires further exploration and understanding.
A comprehensive literature search identified a signifi-
cant number of studies which have assessed various
physical and psychological symptoms of CKD, in a range
of countries, including USA, [18–21] UK, [22, 23], and
Canada [24]. A single cross sectional study has assessed
the various physical and psychological symptoms of
CKD, for individuals living in Saudi Arabia [11]. Studies
suggest that demographic data and clinical variables can
potentially influence the individual’s symptom experi-
ences in different diseases [11, 18, 20, 22, 23, 25–30].
Previous studies have failed to explore symptom burden,
its impact and its management using a mixed methods
explanatory study design, particularly in Saudi Arabia.
Patients with CKD often rely on others to help with
their medical needs and daily living activities [31].
Family caregivers are essential partners in the delivery
of complex healthcare services. The number of people
living with patients receiving HD has increased due
to the increase in the prevalence of kidney disease
[32]. The most frequent responsibilities undertaken by
caregivers of those receiving HD, include supervision
of the patient’s nutrition and hygiene, driving patients
to treatment sessions, and administering medications.
Completing these responsibilities may have negative
life experience for caregivers of patients receiving HD
[33]. Recent literature suggests that the informal care-
giver role in patient requiring dialysis, causes feelings
of being overwhelmed and greater burden [34]. There
is a lack of evidence regarding understanding the as-
sociation between caregiver burden and patient
burden.
There are a number of factors associated with different
experiences of caregiver burden such as living with the
patient [35], age [36–39], gender [37–43], education
[39], socioeconomic status [33, 44], relationship to the
patient [37, 38] and comorbidity [41, 45, 46]. The bur-
den on caregivers of chronically ill patients has received
less attention and commonly focuses on psychiatric ill-
ness such as dementia [47–52], breast cancer [53, 54]
and with limited research interest considering caregiver
burden in CKD [34, 55, 56].
This study aims to explore symptom burden, its self-
management, and the factors predicting symptom
burden in patients undergoing HD. It also aims to assess
the level of burden in the caregivers of these patients,
the relationship between patient and caregiver burden,
and to explore factors that may influence reporting of
patient and caregiver burden.
Research questions
This study seeks to answer the following research
questions:
Phase 1-A quantitative phase with patients
 What is the level of symptom burden for patients
receiving HD?
 What are the factors that predict symptom burden
among patients receiving HD?
Phase 1-B Quantitative phase for caregivers.
For caregivers of patients receiving HD:
 What is the level of caregiver burden?
 What are the factors that predict caregiver burden?
 What is the association between patient symptom
burden and caregiver burden?
Phase 2 Qualitative phase - patients and caregivers
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 What is the experience of symptom burden for
patients receiving HD?
 What is the experience of caregiver burden for
caregivers of patients receiving HD?
 What management strategies are used by patients
receiving HD to manage symptoms?
Integration question:
How do the insights gained from the qualitative data
help to explain the impact of symptom burden and the
factors associated with symptom and caregiver burden
identified in the quantitative analysis?
Design and methods
The study will apply a mixed methods sequential ex-
planatory design with a quantitative phase followed by a
qualitative phase [57]. The aim of this study is not only
to identify symptom burden, its management, and the
factors predicting patient and caregiver burden; it also
aims to provide an understanding of the impact of living
with burden and how these factors may influence report-
ing of caregiver and patient burden. Phase 1 will use a
cross-sectional design to measure symptom burden
using the Chronic Kidney Disease Symptom Burden
Index (CKD-SBI) Arabic version questionnaire [58].
Caregiver burden will be collected using the 22-item ver-
sion of the Zarit Burden Interview (ZBI-22) [59]. Phase
2 is a qualitative descriptive design involving a number
of semi-structured interviews, which will aid the inter-
pretation of Phase 1 findings, by providing a context
within which the quantitative data can be understood
[57]. A sequential explanatory design can be used to en-
hance understanding of quantitative research findings by
providing supporting evidence from the qualitative phase
of the study [60]. The main focus of qualitative inter-
views is to provide an in-depth understanding of the sig-
nificant, unexpected or unexplained results which may
arise during the quantitative phase, such as individuals
who reported extreme symptom burden scores, either
low or high [61, 62]. Qualitative interviews will also
explore the impact of living with symptoms in patients
receiving HD and their caregivers as well as to discuss
the self-management strategies that might be used by
patients to reduce or relieve their symptoms. In this
study, the quantitative phase will be the dominant area
of investigation; with the qualitative phase taking a
secondary explanatory role. The quantitative data will be
analysed and these provisional results will be used to
help guide qualitative data collection. When both
qualitative and quantitative data is collected, results
will be integrated to provide insight into symptom
experience, caregiver experience and how predictors
contribute to increase the level of burden. It will also
help to illustrate any differences between the
management strategies used by patients with different
levels of symptom burden. (see Fig. 1).
Setting
The research will be completed within the HD centre at
King Khaled Hospital, Hail City, in northern Saudi Arabia.
This 284 bed hospital contains various specialist areas, in-
cluding the HD centre. Approximately 240 patients attend
the HD centre each week. The centre is open 6 days a week;
each day is divided into two shifts (morning and evening).
Each shift receives around 60 patients for HD treatment.
The King Khaled Hospital is the only hospital within the re-
gion that provides HD treatment for patients with ESRD.
Study population
Patients
To be eligible for study recruitment patients must have
received regular HD therapy for more than 3 months, be
able to communicate in English or Arabic, are aged 18
years or older, and are cognitively able to participate in
the study. Cognitive assessment will be completed by
the nephrologist within the HD treatment area. Patients
receiving peritoneal dialysis or conservative management
will be excluded from participation in the study.
Fig. 1 Research process for Explanatory Sequential Design
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Caregivers
Eligible caregivers must be aged over 18 years and be iden-
tified by the patient as the key caregiver who provides
some level of practical help and support for more than 3
months. Caregivers will only be recruited into the study
when patients consent to their participation. They must
be able to communicate, read and write in English or




The primary outcome of this study is to measure symp-
tom burden in patients receiving HD. The study will also
identify the impact on symptom burden in relation to
the following possible predictors: age, gender, education
level, marital status, income, co-morbidity, employment,
living distance from hospital, and the duration of dialy-
sis. A power calculation was performed using GPower
software [63] to help avoid type 11 error and calculate
the sample size required. Given a medium effect size
(f2 = 0.15), significance level of 5, 90% power and 9 pre-
dictors, the sample size required is 141 patients receiv-
ing HD. Similarly, for 7 predictor variables, the study
needs to recruit 130 caregivers. The number of people
available in the hospital who receive HD is 240. A previ-
ous study involving this population was able to recruit a
larger number of participants [58], so this study is likely
to recruit the required number of participants to help
ensure the credibility of findings.
For the exploratory qualitative interviews, we antici-
pate a sample of approximately 15–20, participants in
both patient and caregiver groups will be sufficient to
achieve data saturation [64]. The data emerging from
respondent interviews will be kept under review as
interviews progress, and no further interviews will be
completed when it becomes clear that no new themes
will emerge from subsequent data [65, 66]. Decisions
can therefore be made prior to coding and thematic
development [67].
Recruitment (see Fig. 2)
Phase 1: cross-sectional study
A renal unit staff member, will act as a gatekeeper and will
be involved in the process of pre-screening and recruiting
patients at the centre. If potential participants who meet
the inclusion and exclusion criteria acknowledge interest,
the gatekeeper will introduce them to the researcher. Par-
ticipants will be provided with an information sheet out-
lining the study and a consent form, to be returned if they
are willing to participate. Participants will be given at least
24 h to consider whether they wish to participate in the
study or not. When patients sign the consent form, the
questionnaire will be distributed and completed by
patients during their HD sessions. The researcher will
provide explanations and assistance to the patients who
are unable to complete the questionnaire, due to either a
lack of understanding or physical restrictions imposed by
the dialysis treatment, such as the presence of cannulas or
cuff pressure on the patients’ arms.
Patients will be asked to identify the person who is pri-
marily involved in their care, this will allow identification
of the most appropriate caregivers to be included in the
study. The information sheet and caregiver question-
naire will then be sent to caregivers in a sealed envelope
via the patient. The information sheet will include an in-
vitation to contact the researcher should the caregiver
have any questions. The sealed envelope will also include
a separate form asking caregivers whether they are
happy to be contacted at a later date to determine if they
would like to be interviewed (consent to be contacted
form). Questionnaires, and (if the caregiver wishes, the
consent to be contacted form) will be returned to the
researcher in the stamped addressed envelope provided.
Returning the questionnaire will be judged to imply
consent.
Fig. 2 Flow diagram illustrating study procedures
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The literature reports that the majority of caregivers
are likely to be women [68], and that female patients re-
port higher symptom burdens [11]. We will collect data
on the proportion of participating patients and care-
givers who are women and this will be taken into
account in our regression analysis.
Phase 2: qualitative descriptive design
The researcher will identify those patients with the top
five highest, median and lowest scores from the CKD-
SBI using SPSS and their caregivers. If these patients
and their associated caregivers refuse to participate in
the study, participants with the next highest, median and
low scores will be recruited. Potential participants will
be contacted and provided with an information sheet
explaining the nature and purpose of interviews and
consent. The researcher and study participants will meet
at an agreed private location to conduct each interview.
Caregivers who prefer a telephone interview will be sent
a consent form, which can be returned via the patient or
by the supplied and stamped addressed envelope. Once
consent is obtained the telephone interview will be ar-
ranged. To help maximise the response rate, caregivers
who do not return the questionnaire within a three-
week period will be sent a reminder letter via the
patients. The interview questions will be formulated
following the analysis of quantitative findings. Interviews
will be of approximately 30–60 min duration.
Instruments
Patients
Symptom burden will be measured using the Chronic
Kidney Disease Symptom Burden Index (CKD-SBI)
Arabic version questionnaire [11]. CKD-SBI is the modi-
fied version of the Dialysis Symptom Index (DSI) and
used widely to assess symptoms in CKD and ESRD.
Testing of the Arabic CKD-SBI has shown it to have
good psychometrics and excellent internal consistency
(Cronbach’s α = 0.91) as well as good reliability and val-
idity in CKD population [58]. The CKD-SBI was adapted
to assess various aspects of symptom burden [11]. These
include assessment of the burden of the disease, and the
prevalence, frequency, distress and severity of each
symptom. A total of 32 CKD symptoms are assessed.
Three empty fields were provided to allow individuals to
add symptoms not identified on the symptom list. The
purpose of the prevalence scale is to assess each symp-
tom’s presence or absence using (Yes/No). Prevalence
scores range from 0 to 32. 0 is lowest prevalence score
while a score of 32 is the highest possible score. Three
further factors will be measured (distress, severity and
frequency) on a scale of 0 to 10 for each respondent’s
rating and will be recorded as, Distress: from none to
highly distressed; Severity: none to extremely intense;
and Frequency: from never to frequent. The highest pos-
sible score for each scale is 320, which is considered to
constitute extremely high burden.
Caregivers
The ZBI scale was developed to assess the level of bur-
den for those caring for patients with dementia. It has
recently been used to assess caregiver burden in CKD
[55, 69, 70]. It contains 22 items, which examine five
caregiver burden domains: burden on the relationship;
loss of control over life; finance; social and family life;
and emotional well-being. The questionnaire items will
be rated using a five-point Likert scale, with 0 (rarely)
being the lowest, and 4 (nearly always) being the highest.
Zarit et al. [49] suggest summing all response scores to
show the level of caregiver burden, with 0 to 20 showing
no burden or slight burden; 21 to 40 indicating mild to
moderate burden; 41 to 60 moderate and severe burden;
and 61 to 88 indicating a heavy burden [71]. ZBI was
translated into Arabic and shows good validity [72, 73].
Reliability of the translated instruments was also tested
and found to be 0.97 [48]. The ZBI has excellent internal
consistency α = 0.83 [74], and α = 0.89 [49, 75]. User
agreement required to use the Arabic version of ZBI was
obtained from the Mapi Research Trust.
Data sources (method of assessment)
Phase 1: cross-sectional study
The primary outcome of this study is to explore symp-
tom burden and its management in patients receiving
HD using the CKD-SBI. In addition, demographic infor-
mation will be collected and will include: age; gender;
marital status; education level; employment status; ethni-
city; income, distance from hospital. Co-morbidities and
duration of dialysis will be obtained from dialysis charts
or hospital records. Co-morbidity will be measured
using the Davies Co-morbidity Index [76]. To measure
caregiver burden, ZBI-22 will be used. The demograph
characteristic of caregivers will be also obtained. All
instruments that will be used in the study have demon-
strated validity and reliability [58, 59].
Phase 2: qualitative descriptive design
In-depth semi-structured qualitative interviews will be
completed to identify the management behaviours used
by patients receiving HD to reduce their symptom dis-
tress. Semi-structured interviews will be used to en-
courage, respondents to discuss important matters that
may have been missed during the quantitative stage of
the study. Participants will have the opportunity to
voice their personal, unique ways of managing, control-
ling and coping with symptoms. Each interview will
also explore their experiences of renal and non-renal
health care and other support services. The impact of
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burden in both patients’ and caregivers’ lives also will
be investigated. Caregivers will be interviewed separ-
ately, to ensure that the information they provide will
not be influenced by the presence of patients. This will
help to ensure the accuracy of information, and assist
in obtaining a deeper understanding of the caregiving
experience, identifying the negative and positive effects
of providing care.
Data analysis
Phase 1: cross-sectional study
Simple descriptive statistics analysis will be provided for
the scale and categorical variables using the Statistical
Package for the Social Sciences (SPSS). For scale vari-
ables, mean and standard deviation will be reported for
the normally distributed data, or alternatively, median
and interquartile range (IQR) will be used for the
skewed distributed data. For categorical variables, abso-
lute frequency (n) and relative frequency (percentage)
(%) of the response, such as gender, education level,
marital status, monthly income, and HB level will be
reported. Correlations between any pairs of continuous
variables will be presented using Pearson’s correlation
coefficients. Chi-square or Fisher’s exact tests for cat-
egorical data and continuous variables will be used to
highlight associations between both samples. Multiple
linear regression analysis will be used for both samples
to identify any association between burden scores,
demographics characteristics and other variables.
Phase 2: qualitative descriptive design
Interviews will be analysed using thematic analysis [77, 78].
Audio-recorded interviews will be transcribed in Arabic by
the researcher and translated by a certified bilingual
translator into English. The researcher will review the final
version of the translation to ensure the credibility of trans-
lation. The translator will sign a non-disclosure form to
guarantee confidentiality of the participants’ data. The data
will then be stored electronically to allow for coding and
analysis. Coding will be managed using NVivo qualitative
data analysis software Version 10 [79]. The analysis will be
based on three phases: data reduction, data display and
conclusion drawing/verification process [66]. Findings will
be discussed and verified with researcher colleagues at
every stage to ensure the accuracy of interpretation, ensure
reliability and promote rigour. By the use of coding re-
searchers can identify themes and patterns in interviews’,
this can be determined by the words used including word
frequency, relationships between words, and how commu-
nication is structured [80]. Codes can then be displayed or
organised to give greater clarification of the content and
allow the drawing of conclusions.
Integration
This is the process of mixing, linking or interacting
between the qualitative and quantitative findings of a
study. This process is a significant element of mixed
methods research [81]. There are several approaches to
integrating qualitative and quantitative research methods
and data [60, 82]. In this study, integration will occur at
the design, methods and interpretation stages of the study.
Integration through design: an exploratory sequential
mixed methods design using both qualitative and quanti-
tative research approaches is suitable to gain a compre-
hensive understanding of the symptom experience of
patients receiving HD, and to help understand the
factors which may increase the level of symptom burden.
It is also important to understand the variety of symp-
tom management strategies which are used by patients
with high, median and low levels of symptom burden.
Integration at the methods stage, occurs by linking the
method of data collection or analysis [83]. In this study,
two approaches will be used to ensure linking, including
connection and building [84]. Connection will be
achieved when participants are selected from the popu-
lation who respond to the survey. Building occurs when
quantitative research findings are used to inform sample
selection for the qualitative phase of the study. Based on
symptom burden scores, in the quantitative phase of the
study, patients will be selected to participate in semi-
structured interviews. Patients with high, middle and
low symptom burden scores, will be assigned to be in-
volved in semi-structured interviews. Building will also
be achieved when results from quantitative data analysis,
inform qualitative data collection. Interview questions
will be modified based on the quantitative study findings
to help meet the aim of the study..
Integration at the interpretation stage will be achieved
using a narrative approach that describes the quantita-
tive and qualitative results thematically [84]. Quantita-
tive and qualitative findings will be synthesized through
narratives, in the study results and discussion by the use
of weaving, where the data weaves back and forth,
around similar themes or concepts [84]. This approach
will help to provide comparisons and contrasts between
findings and help to draw out new insights beyond the
symptom experience, identified in the quantitative and
qualitative findings.
Rigour
In a mixed methods design, researchers need to ensure
the validity and trustworthiness of the study findings.
The following strategies will be applied to enhance
rigour in the sequential explanatory design: the use of
well-validated and reliable instruments to collect data in
the dominant quantitative phase, determination of the
important findings that emerge from the quantitative
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phase to help recruit participants and guide data collec-
tion in the qualitative exploration, analysing the qualita-
tive data independently and then in relation to the
quantitative findings. Findings will be discussed and veri-
fied with the involved researchers at every stage to assess
the accuracy of the interpretation, improve reliability
and ensure a rigour. To ensure credibility and transfer-
ability, thick descriptions will be provided to enable
judgments about how the results are believable and
reflected in the data and how likely the context of this
study will fit with other populations, settings and
contexts. The Good Reporting of A Mixed Methods
Study (GRAMMS) guidelines will be used to assist the
quality of reporting and help enhance the transparency
of the study processes [85].
Study approvals
The study protocol has been approved by the Research
Ethics Committees at Queen’s University Belfast, UK, in
September 2017, reference number 10.BAlshammar-
i05.17.M6.V1. It has also been approved by Hail Univer-
sity, Saudi Arabia, and the research and education
centre of King Khaled Hospital, Saudi Arabia, where the
study will be conducted. The study is sponsored by the
Ministry of Education, University of Hail, Saudi Arabia
and permission to access patients at the HD centre has
been granted.
Discussion
This study will use a sequential explanatory mixed
methods design to explore a wide number of symptoms
and explain symptoms experienced by patients receiving
HD. It will also coneptualises the management strategies
patients use to help cope with these symptoms. The
research findings will make a significant contribution to
understand the symptoms experienced in patients
receiving HD. This is the first study which utilizes a
qualitative approach to explore the symptom experience
and caregiver burden in patients receiving HD in Saudi
Arabia. In-depth understanding of symptom burden will
provide guidance for health care providers to develop in-
terventions for assessing and managing symptoms in the
future. Appropriate interventions to manage symptoms
will help to improve the quality of care and lead to im-
proved health-related quality of life for patients with
CKD. This study also provides valuable insights into
caregivers experiences of patients receiving HD which
will enable health professionals to better understanding
caregiver burden and related stress. Finally, the collec-
tion of both qualitative and quantitative data will facili-
tate a more holistic understanding of symptom burden
and management in both patients and their caregivers.
The limitations of this study include the use of a con-
venience sample in the quantitative phase of the study.
With the use of convenience sampling there is an in-
creased risk of bias, as study participants may not accur-
ately reflect the characteristics of the total population.
An additional limitation of the study is that interviews
will be translated from Arabic to English. It is possible
that the real meanings of Arabic words may be misinter-
preted with translation. To help address this potential
limitation, the quality of translations will be assessed
independently by an additional bilingual translator to
ensure accuracy.
Abbreviation
CKD: Chronic kidney disease; CKD-SBI: Chronic Kidney Disease Symptom
Burden Index; ESRD: End-stage renal disease; HD: Haemodialysis; ZBI-22: The
22-item version of the Zarit Burden Interview
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